Page 134 - Informatorium Obat COVID-19 di Indonesia

revision-1_en.pdf. Diakses 31 Maret 2020.
54. https://www.hse.ie/eng/about/who/acute-hospitals-
division/drugs-management-
programme/guidelines/specific-antiviral-therapy-in-the-
clinical-management-of-acute-respiratory-infection-with-
sars-cov-2-COVID-19.pdf. Diakses pada 31 Maret 2020.
55. https://www.apsf.org/ddi/summary-of-chloroquine-and-
hydroxychloroquine-drug-drug-interactions/. Diakses pada
31 Maret 2020.
56. Könnyű B, Sadiq SK, Turányi T, Hírmondó R, Müller B,
Kräusslich H-G, et al. (2013) Gag-Pol Processing during
HIV-1 Virion Maturation: A Systems Biology Approach. PLoS
Comput Biol 9(6): e1003103.
https://doi.org/10.1371/journal.pcbi.1003103. Diakses
30 Maret 2020.
57. https://pubchem.ncbi.nlm.nih.gov/compound/Lopinavir.
Diakses 30 Maret 2020.
58. https://www.drugbank.ca/drugs/DB00503. Diakses 30
Maret 2020.
59. https://pubchem.ncbi.nlm.nih.gov/compound/392622.
Diakses 30 Maret 2020.
60. https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?di
ctionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C160
9. Diakses 30 Maret 2020.
61. Bin Cao, M.D., Yeming Wang, M.D., Danning Wen, M.D., et
al. 2020. A Trial of Lopinavir–Ritonavir in Adults
Hospitalized with Severe Covid-19.
(https://www.nejm.org/doi/full/10.1056/NEJMoa200128
2). Diakses 30 Maret 2020.
62. AVIGAN Leaflet Toyama Chemical. Co., Ltd.
63. Chang,.C, et al. Favipiravir versus Arbidol for COVID-19: A
Randomized Clinical Trial. medRxiv.
64. Cai, Q., et al. 2020. Experimental Treatment with
Favipiravir for COVID-19: An Open-Label Control Study.
Engineering.
65. Furuta, Y., et al. 2009. T-705 (favipiravir) and related
compounds: Novel broad-spectrum inhibitors of RNA viral
infections. J. of Antiviral Rsch., 82(3):95-102.

125